ANI Pharmaceuticals Inc (ANIP)

61.44 +0.53  +0.87% NASDAQ Feb 21, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/08/2020 10:30 EDT Misc ANI Pharmaceuticals Inc First Quarter Earnings Conference Call in 2020
05/08/2020 Earnings ANI Pharmaceuticals Inc First Quarter Earnings in 2020 Release
02/27/2020 10:30 EST Misc ANI Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/27/2020 Earnings ANI Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
11/06/2019 10:30 EST Misc ANI Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
11/06/2019 Earnings ANI Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
08/07/2019 10:30 EDT Misc ANI Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings ANI Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
05/14/2019 09:00 EDT Misc ANI Pharmaceuticals Inc Annual General Meeting in 2018
05/09/2019 10:30 EDT Misc ANI Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.anipharmaceuticals.com
  • Investor Relations URL: http://www.anipharmaceuticals.com/investors_corporate_profile.php
  • HQ State/Province: Minnesota
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Feb. 27, 2020
  • Last Earnings Release: Nov. 06, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: ANI Pharmaceuticals Inc develops, manufactures and markets generic prescription pharmaceuticals, made in the U.S.A. It manufactures liquid, powder and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone, and Vancomycin.

Top Fund Holders

Symbol Name Weighting
RFIMX Ranger Micro Cap Institutional 4.22%
PJP Invesco Dynamic Pharmaceuticals ETF 2.71%
PBE Invesco Dynamic Biotech & Genome ETF 2.70%
DSCEX Dana Small Cap Equity Investor 1.81%
XPH SPDR® S&P Pharmaceuticals ETF 1.19%
RBF199 RBC O'Shaughnessy U.S. Growth Fund O 1.12%
WTMIX Segall Bryant & Hamill Micro Cap Retail 1.03%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.